DGIdb - EXATECAN MESYLATE Drug Record

EXATECAN MESYLATE chembl:CHEMBL3989759

Alternate Names:

EXATECAN METHANESULFONATE DIHYDRATE
EXATECAN MESILATE HYDRATE
EXATECAN MESILATE DIHYDRATE
DX-8951F
EXATECAN MESYLATE

Drug Info:

(0 More Sources)

Publications:

Okamoto et al., 2002, O(6)-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives., Jpn. J. Cancer Res.
Okamura et al., 2000, NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy., Int. J. Oncol.

EXATECAN MESYLATE MGMT

Interaction Score: 3.36

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11802813

Sources:
NCI
EXATECAN MESYLATE GSTP1

Interaction Score: 1.33

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10639573

Sources:
NCI

NCI: DX-8951F

Version: 14-September-2017

Alternate Names:

C1679 NCI drug code

Drug Info:

Publications:

Okamura et al., 2000, NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy., Int. J. Oncol.

Okamoto et al., 2002, O(6)-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives., Jpn. J. Cancer Res.

ChemblDrugs: chembl:CHEMBL3989759
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications: